Peripheral iron metabolism in patients with Parkinson's disease. 1994

F Cabrera-Valdivia, and F J Jiménez-Jiménez, and J A Molina, and P Férnandez-Calle, and A Vázquez, and F Cañizares-Liébana, and S Larumbe-Lobalde, and L Ayuso-Peralta, and M Rabasa, and R Codoceo
Department of Neurology, Hospital Universitario Príncipe de Asturias Alcalá de Henares, Madrid, Spain.

To elucidate the possible role of peripheral metabolism of iron in the risk for developing Parkinson's disease (PD), we compared serum levels of iron, transferrin and ferritin, and 24-h iron excretion in urine after a single intramuscular dose of 1 mg/kg desferrioxamine, in 68 PD patients and their spouses as the control group. All these values did not differ significantly between the groups, they were not influenced by antiparkinsonian therapy, and they did not correlate with age, age at onset and duration of the disease, scores of the Unified PD Rating Scale or the Hoehn and Yahr staging in the PD group, with the exception of the 24-h urinary iron excretion with the duration of the disease (r = 0.32, p < 0.05). These results suggest that peripheral metabolism of iron is apparently unrelated to the risk of developing PD.

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D003676 Deferoxamine Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. Desferrioxamine,Deferoxamine B,Deferoxamine Mesilate,Deferoxamine Mesylate,Deferoxamine Methanesulfonate,Deferoximine,Deferrioxamine B,Desferal,Desferioximine,Desferrioxamine B,Desferrioxamine B Mesylate,Desferroxamine,Mesilate, Deferoxamine,Mesylate, Deferoxamine,Mesylate, Desferrioxamine B,Methanesulfonate, Deferoxamine
D005260 Female Females
D005293 Ferritins Iron-containing proteins that are widely distributed in animals, plants, and microorganisms. Their major function is to store IRON in a nontoxic bioavailable form. Each ferritin molecule consists of ferric iron in a hollow protein shell (APOFERRITINS) made of 24 subunits of various sequences depending on the species and tissue types. Basic Isoferritin,Ferritin,Isoferritin,Isoferritin, Basic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F Cabrera-Valdivia, and F J Jiménez-Jiménez, and J A Molina, and P Férnandez-Calle, and A Vázquez, and F Cañizares-Liébana, and S Larumbe-Lobalde, and L Ayuso-Peralta, and M Rabasa, and R Codoceo
January 1998, Movement disorders : official journal of the Movement Disorder Society,
F Cabrera-Valdivia, and F J Jiménez-Jiménez, and J A Molina, and P Férnandez-Calle, and A Vázquez, and F Cañizares-Liébana, and S Larumbe-Lobalde, and L Ayuso-Peralta, and M Rabasa, and R Codoceo
May 2024, European radiology,
F Cabrera-Valdivia, and F J Jiménez-Jiménez, and J A Molina, and P Férnandez-Calle, and A Vázquez, and F Cañizares-Liébana, and S Larumbe-Lobalde, and L Ayuso-Peralta, and M Rabasa, and R Codoceo
September 1997, Neurology,
F Cabrera-Valdivia, and F J Jiménez-Jiménez, and J A Molina, and P Férnandez-Calle, and A Vázquez, and F Cañizares-Liébana, and S Larumbe-Lobalde, and L Ayuso-Peralta, and M Rabasa, and R Codoceo
May 2017, Molecular neurobiology,
F Cabrera-Valdivia, and F J Jiménez-Jiménez, and J A Molina, and P Férnandez-Calle, and A Vázquez, and F Cañizares-Liébana, and S Larumbe-Lobalde, and L Ayuso-Peralta, and M Rabasa, and R Codoceo
January 2017, Brain research,
F Cabrera-Valdivia, and F J Jiménez-Jiménez, and J A Molina, and P Férnandez-Calle, and A Vázquez, and F Cañizares-Liébana, and S Larumbe-Lobalde, and L Ayuso-Peralta, and M Rabasa, and R Codoceo
January 2022, Frontiers in aging neuroscience,
F Cabrera-Valdivia, and F J Jiménez-Jiménez, and J A Molina, and P Férnandez-Calle, and A Vázquez, and F Cañizares-Liébana, and S Larumbe-Lobalde, and L Ayuso-Peralta, and M Rabasa, and R Codoceo
April 1998, Neurology,
F Cabrera-Valdivia, and F J Jiménez-Jiménez, and J A Molina, and P Férnandez-Calle, and A Vázquez, and F Cañizares-Liébana, and S Larumbe-Lobalde, and L Ayuso-Peralta, and M Rabasa, and R Codoceo
December 2020, Yonsei medical journal,
F Cabrera-Valdivia, and F J Jiménez-Jiménez, and J A Molina, and P Férnandez-Calle, and A Vázquez, and F Cañizares-Liébana, and S Larumbe-Lobalde, and L Ayuso-Peralta, and M Rabasa, and R Codoceo
January 2021, Frontiers in aging neuroscience,
F Cabrera-Valdivia, and F J Jiménez-Jiménez, and J A Molina, and P Férnandez-Calle, and A Vázquez, and F Cañizares-Liébana, and S Larumbe-Lobalde, and L Ayuso-Peralta, and M Rabasa, and R Codoceo
January 2010, Advances in gerontology = Uspekhi gerontologii,
Copied contents to your clipboard!